Canadian Prime Minister Justin Trudeau announced Friday a deal with AstraZeneca to procure up to 20 million doses of its COVID-19 vaccine candidate being developed with Oxford University.
Sep 25, 2020
0
3
A politically engaged electorate is key to any thriving democracy, but not everyone participates in elections and other political activities. New research found that people who are narcissistic may also be more politically ...
Sep 25, 2020
0
9
In a paper published in the Journal on Active Aging, University of Illinois Chicago longevity researcher S. Jay Olshansky and his colleagues conclude that both 2020 presidential candidates—former Vice President Joe Biden, ...
Sep 25, 2020
0
5
French pharmaceutical firm Sanofi and Britain's GSK have promised up to 72 million doses of their COVID-19 vaccine candidate to the Canadian government, which has already signed similar agreements with several American companies.
Sep 22, 2020
0
2
New research suggests that the impact of natural and vaccine-induced immunity will be key factors in shaping the future trajectory of the global coronavirus pandemic, known as COVID-19. In particular, a vaccine capable of ...
Sep 21, 2020
0
53
A China-developed coronavirus vaccine could be ready for the public as early as November, a Chinese official has told state television, as the global race to clear the final round of trials heats up.
Sep 15, 2020
0
91
Late-stage studies of AstraZeneca's COVID-19 vaccine candidate are on temporary hold while the company investigates whether a recipient's "potentially unexplained" illness is a side effect of the shot.
Sep 9, 2020
0
34
China has put its homegrown coronavirus vaccines on display for the first time, as the country where the contagion was discovered looks to shape the narrative surrounding the pandemic.
Sep 7, 2020
0
8
The World Health Organization says it does not expect widespread immunisation against Covid-19 until mid-2021, despite growing expectations in the United States, the worst-hit nation, that a vaccine could be released within ...
Sep 4, 2020
0
18
A bioengineering technique to boost production of specific proteins could be the basis of an effective vaccine against the novel coronavirus that causes COVID-19, new research suggests.
Sep 2, 2020
0
304
